Reference values of serum total IgE in Uppsala - comparison over four decades.

Allergy asthma atopy reference value total IgE upper limit of normal

Journal

Upsala journal of medical sciences
ISSN: 2000-1967
Titre abrégé: Ups J Med Sci
Pays: Sweden
ID NLM: 0332203

Informations de publication

Date de publication:
2023
Historique:
received: 18 08 2023
revised: 10 11 2023
accepted: 13 11 2023
medline: 12 12 2023
pubmed: 12 12 2023
entrez: 12 12 2023
Statut: epublish

Résumé

Total immunoglobulin E (IgE) analysis is a common tool in allergy diagnosis. Suggested reference values for IgE are divergent and sometimes based on outdated assay methods. We aimed to validate the published reference values (geometric mean [GM]: 13.2 kU/L, upper limit of normal [ULN], 114 kU/L) shown in an Uppsala cohort from 1974 using Phadebas IgE PRIST, and the suggested clinical threshold of 100 kU/L (Zetterström and Johansson 1981). Immunoglobulin E was measured in two Uppsala cohorts from 1997 (Blood bank) and 2011 to 2013 (the European community respiratory health survey part III [ECRHS III]) using ImmunoCAP™ Total IgE. For the reference value calculations, exclusion criteria were atopy (both cohorts), doctor's diagnosis of asthma and self-reported allergy (hay fever, rhinitis, rash) (only ECRHS III). Upper limit of normal was defined as mean + 2 standard deviations (SD) calculated using log-transformed values and back-transformation of the ULN prior to presentation. Common imputation methods for results below the assay range were evaluated. The average GM was 14.2 kU/L (Blood bank, The calculated ULN values were similar between the cohorts. We conclude that the total IgE reference values shown for Uppsala subjects from 1974 are still valid and suitable also for the ImmunoCAP Total IgE assay. The 100 kU/L threshold for total IgE had a low sensitivity but high specificity for atopy, asthma, and allergy.

Sections du résumé

Background UNASSIGNED
Total immunoglobulin E (IgE) analysis is a common tool in allergy diagnosis. Suggested reference values for IgE are divergent and sometimes based on outdated assay methods. We aimed to validate the published reference values (geometric mean [GM]: 13.2 kU/L, upper limit of normal [ULN], 114 kU/L) shown in an Uppsala cohort from 1974 using Phadebas IgE PRIST, and the suggested clinical threshold of 100 kU/L (Zetterström and Johansson 1981).
Methods UNASSIGNED
Immunoglobulin E was measured in two Uppsala cohorts from 1997 (Blood bank) and 2011 to 2013 (the European community respiratory health survey part III [ECRHS III]) using ImmunoCAP™ Total IgE. For the reference value calculations, exclusion criteria were atopy (both cohorts), doctor's diagnosis of asthma and self-reported allergy (hay fever, rhinitis, rash) (only ECRHS III). Upper limit of normal was defined as mean + 2 standard deviations (SD) calculated using log-transformed values and back-transformation of the ULN prior to presentation. Common imputation methods for results below the assay range were evaluated.
Results UNASSIGNED
The average GM was 14.2 kU/L (Blood bank,
Conclusion UNASSIGNED
The calculated ULN values were similar between the cohorts. We conclude that the total IgE reference values shown for Uppsala subjects from 1974 are still valid and suitable also for the ImmunoCAP Total IgE assay. The 100 kU/L threshold for total IgE had a low sensitivity but high specificity for atopy, asthma, and allergy.

Identifiants

pubmed: 38084204
doi: 10.48101/ujms.v128.9892
pii: 9892
pmc: PMC10710850
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023 The Author(s). Published by Upsala Medical Society.

Déclaration de conflit d'intérêts

Robert Movérare is employed by Thermo Fisher Scientific (and minor shareholder). Eilif Persson is retired from the company. The other authors declare no conflict of interest.

Références

Clin Allergy. 1976 Jan;6(1):51-9
pubmed: 1248098
J Allergy Clin Immunol. 2016 Jun;137(6):1788-1795.e9
pubmed: 26586040
Int Arch Allergy Immunol. 2007;142(3):230-8
pubmed: 17108704
Clin Exp Allergy. 2016 May;46(5):730-40
pubmed: 26243058
J Allergy Clin Immunol. 1997 Mar;99(3):314-22
pubmed: 9058686
Immun Inflamm Dis. 2023 Jan;11(1):e751
pubmed: 36705407
J Allergy Clin Immunol. 2011 May;127(5):1226-35.e7
pubmed: 21320720
World Allergy Organ J. 2020 Feb 25;13(2):100080
pubmed: 32128023
JAKSTAT. 2013 Apr 1;2(2):e23435
pubmed: 24058807
J Allergy Clin Immunol. 2014 Feb;133(2):589-91
pubmed: 24139495
Allergy. 2003 Sep;58(9):905-11
pubmed: 12911420
Eur J Immunol. 2007 May;37(5):1170-3
pubmed: 17447233
Bull World Health Organ. 1970;43(4):609-11
pubmed: 5313076
Allergy. 1990 May;45(4):285-92
pubmed: 2382793
Allergy. 1996 Nov;51(11):770-6
pubmed: 8947333
J Biol Stand. 1981 Oct;9(4):431-7
pubmed: 7320024
Am J Epidemiol. 2003 Feb 15;157(4):355-63
pubmed: 12578806
Allergy. 1981 Nov;36(8):537-47
pubmed: 7337200
J Allergy Clin Immunol. 2009 Sep;124(3):447-53
pubmed: 19647861
J Transl Med. 2015 Jul 18;13:236
pubmed: 26187732

Auteurs

Robert Movérare (R)

Thermo Fisher Scientific, Uppsala, Sweden.
Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden.

Eilif Persson (E)

Thermo Fisher Scientific, Uppsala, Sweden.

Andrei Malinovschi (A)

Department of Medical Sciences: Clinical Physiology, Uppsala University, Uppsala, Sweden.

Christer Janson (C)

Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden.

Classifications MeSH